<DOC>
	<DOCNO>NCT02449616</DOCNO>
	<brief_summary>The purpose study evaluate safety repeat administration MST-188 vaso-occlusive crisis sickle cell disease . Additionally , study evaluate development acute chest syndrome VOC re-hospitalization recurrence VOC .</brief_summary>
	<brief_title>Evaluation Repeat Administration Purified Poloxamer 188</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Completed participation study MST18801 ( EPIC study ) Subject age 4 65 year Subject experience acute pain typical VOC require treatment parenteral opioid analgesia Subject require hospitalization Subject acute chest syndrome Subject 's laboratory result indicate inadequate organ function Subject pregnant nursing infant Subject painful crisis require hospitalization within precede 14 day Subject transfuse within past 14 day Subject complication relate SCD</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Sickle cell</keyword>
	<keyword>vaso-occlusive crisis</keyword>
</DOC>